ArticleBMC medical research methodology2022

Pharmacokinetic parameter driven outcomes model predicts a reduction in bleeding events associated with BAY 81-8973 versus antihemophilic factor (recombinant) plasma/albumin-free method in a Chinese healthcare setting.

Rong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.